Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

por Feliu, J, Castañón, C, Salud, A, Mel, J R, Escudero, P, Pelegrín, A, López-Gómez, L, Ruiz, M, González, E, Juárez, F, Lizón, J, Castro, J, González-Barón, M
Publicado 2005

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

por Feliu, J, Salud, A, Escudero, P, Lopez-Gómez, L, Bolaños, M, Galán, A, Vicent, J-M, Yubero, A, Losa, F, De Castro, J, de Mon, M Á, Casado, E, González-Barón, M
Publicado 2006

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

por Feliu, J, Salud, A, Escudero, P, López-Gómez, L, Pericay, C, Castañón, C, de Tejada, M R López, Rodríguez-García, J M, Martínez, M P, Martín, M Sanz, Sánchez, J J, Barón, M González
Publicado 2004